| MRI contrast-dose relationship of manganese(III)tetra(4-sulfonatophenyl) porphyrin with human xenograft tumors in nude mice at 2.0 T. | |
| | |
MedLine Citation:
|
PMID: 1461089 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Previously we reported that Mn(III)tetra(4-sulfonatophenyl) porphyrin, MnTPPS4, is a contrast agent which can effectively enhance tumor detection by MRI. By imaging 30 additional athymic nude mice bearing subcutaneous MCF-7 WT human breast carcinoma xenografts, we have extended dose-contrast relationships over a wide range of intraperitoneal (IP) doses ranging from 0.025 to 0.50 mmol/kg. The benefits of IP injection are higher possible doses on a volume basis and a reduction in toxicity versus IV administration. Full coronal cross-section images have been obtained on a 2-T spectrometer. Although individual tumor masses displayed different distribution patterns, reflective of their internal morphology, single doses of 0.10 mmol/kg or greater were necessary to produce a detectable effect. At a dose of 0.50 mmol/kg, marked enhancement was produced. Multiple small dosages administered over the course of several days before imaging did not produce increased enhancement. Preliminary results on the new porphyrin derivative, MnTPPS3, indicate that the ratio of the toxic dose to the effective dose may be adjustable to render this class of agents clinically useful. |
| | |
Authors:
|
D A Place; P J Faustino; K K Berghmans; P C van Zijl; A S Chesnick; J S Cohen |
Related Documents
:
|
3031229 - Effect of methylprednisolone on radiotherapy of f344 rats with avian sarcoma virus indu... 2163499 - Experimental neoplastic spinal cord compression: effect of anti-inflammatory agents and... 10919639 - Synergistic antitumor activity of irinotecan in combination with 5-fluorouracil in rats... 15996019 - Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule. 2983889 - Induction of rat pancreatic b-cell tumors by the combined administration of streptozoto... 8538189 - Development of difluoromethylornithine as a chemoprevention agent for the management of... 11377089 - Ion chromatographic determination of calcium and magnesium cations in human saliva and ... 8262729 - A phase i clinical and pharmacological profile of dacarbazine with autologous bone marr... 1084269 - Adrenocortical changes in rats during acute and chronic administration of delta-9-tetra... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Magnetic resonance imaging Volume: 10 ISSN: 0730-725X ISO Abbreviation: Magn Reson Imaging Publication Date: 1992 |
Date Detail:
|
Created Date: 1993-01-14 Completed Date: 1993-01-14 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8214883 Medline TA: Magn Reson Imaging Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 919-28 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology, Georgetown University Medical Center, Rockville, MD 20850. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Breast Neoplasms / diagnosis* Contrast Media* Dose-Response Relationship, Drug Female Humans Magnetic Resonance Imaging Manganese* Metalloporphyrins / diagnostic use* Mice Mice, Nude Transplantation, Heterologous |
| Chemical | |
Reg. No./Substance:
|
0/Contrast Media; 0/Metalloporphyrins; 7439-96-5/Manganese; 88992-32-9/manganese(III)tetraphenylporphine sulfonate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evaluation of two new gadolinium chelates as contrast agents for MRI.
Next Document: Surface coil imaging of rat spine at 7.0 T.